Chronic Obstructive Pulmonary Disease News and Research RSS Feed - Chronic Obstructive Pulmonary Disease News and Research

The World Health Organisation (WHO) has described Chronic Obstructive Pulmonary Disorder (COPD) as a global epidemic; an estimated 210 million people have COPD worldwide and more than 3 million people died of the condition in 2005, which is equal to 5% of all deaths globally that year. Total deaths from COPD are projected to increase by more than 30% in the next 10 years without interventions to cut risks, particularly exposure to tobacco smoke.
Pneumococcal pneumonia mortality falling

Pneumococcal pneumonia mortality falling

Between 2000 and 2013 there has been an increase in the early prescription of antibiotics and use of combination therapy in patients with pneumococcal pneumonia, researchers report. [More]
Researchers receive grant to improve treatment for patients with COPD

Researchers receive grant to improve treatment for patients with COPD

Research into improving treatment for patients with one of the UK's most common respiratory diseases has received a -810,000 funding boost. [More]
Direct medical costs projected to increase to $49 billion annually by 2020

Direct medical costs projected to increase to $49 billion annually by 2020

The American College of Chest Physicians announced today the Online First publication of 'Total and State-Specific Medical and Absenteeism Costs of Chronic Obstructive Pulmonary Disease Among Adults Aged ≥18 Years in the United States for 2010 and Projections Through 2020' in the journal CHEST. [More]
Combination superior to monotherapy for COPD

Combination superior to monotherapy for COPD

Combination treatment with umeclidinium plus vilanterol improves lung function in patients with chronic obstructive pulmonary disease to a greater extent than with VI or tiotropium monotherapy, results show. [More]
Long-acting inhaled combination therapy best for COPD

Long-acting inhaled combination therapy best for COPD

The combination of a long-acting β22-agonist and an inhaled corticosteroid may be the best choice for some patients with chronic obstructive pulmonary disease who need more than short-acting bronchodilators, suggest the results of a Cochrane Collaboration network meta-analysis. [More]
How is the health law working on the local level?

How is the health law working on the local level?

Opened in March, Detroit Central City is the first community mental health clinic in southeast Michigan to become a specially designated, federally qualified health clinic to integrate mental health care with physical health, or primary care. [More]
Surgeon explains who needs screening for abdominal aortic aneurysms

Surgeon explains who needs screening for abdominal aortic aneurysms

Bulges in body's major blood vessel can cause potentially lethal ruptures, blood clots. An abdominal aortic aneurysm is a potentially life-threatening condition: If the body's major blood vessel ruptures, it can prove deadly. [More]
Use of electronic health records simplifies clinical trials

Use of electronic health records simplifies clinical trials

Using electronic health records to understand the best available treatment for patients, from a range of possible options, is more efficient and less costly for taxpayers than the existing clinical trial process, a new study shows. [More]
Tute Genomics agrees to provide NGS analytics for Lineagen's NextStepDx PLUS

Tute Genomics agrees to provide NGS analytics for Lineagen's NextStepDx PLUS

Tute Genomics, the leader in genome annotation and interpretation, today announced an agreement with Lineagen, Inc., to provide next-generation sequencing (NGS) analytics for Lineagen's NextStepDx PLUS. [More]
Depressed COPD patients have difficulty in sticking to pulmonary rehabilitation program

Depressed COPD patients have difficulty in sticking to pulmonary rehabilitation program

Researchers from The Miriam Hospital have found that people with Chronic obstructive pulmonary disease (COPD) who are also depressed have difficulty sticking to a pulmonary rehabilitation program. [More]
Excessive belly fat: A risk factor for chronic obstructive pulmonary disease

Excessive belly fat: A risk factor for chronic obstructive pulmonary disease

Obesity, especially excessive belly fat, is a risk factor for chronic obstructive pulmonary disease (COPD), according to an article in CMAJ (Canadian Medical Association Journal). [More]
Weak hospice oversight makes safety problems hard to identify

Weak hospice oversight makes safety problems hard to identify

The typical hospice undergoes a full government inspection about once every six years, according to The Washington Post, making it one of the least scrutinized areas of U.S. health care. [More]
Afrezza gets FDA approval to improve glycemic control in adults with diabetes mellitus

Afrezza gets FDA approval to improve glycemic control in adults with diabetes mellitus

The U.S. Food and Drug Administration today approved Afrezza (insulin human) Inhalation Powder, a rapid-acting inhaled insulin to improve glycemic control in adults with diabetes mellitus. Afrezza is a rapid-acting inhaled insulin that is administered at the beginning of each meal, or within 20 minutes after starting a meal. [More]
Research: TB infection among people taking corticosteroid pills may be underestimated

Research: TB infection among people taking corticosteroid pills may be underestimated

Tuberculosis infection among people taking corticosteroid pills may be underestimated, new research suggests. [More]
Women are 10% more likely to use mental health services than men

Women are 10% more likely to use mental health services than men

Women with chronic physical illnesses are more likely to use mental health services than men with similar illnesses; they also seek out mental health services six months earlier than those same men, according to new study from St. Michael's Hospital and the Institute for Clinical Evaluative Sciences (ICES). [More]
Emphysema does not worsen lung cancer prognosis beyond pulmonary fibrosis

Emphysema does not worsen lung cancer prognosis beyond pulmonary fibrosis

Patients with combined pulmonary fibrosis and emphysema who are undergoing treatment for advanced lung cancer do not have a significantly worse prognosis than their counterparts with isolated idiopathic interstitial pneumonias, report Japanese researchers. [More]
Study demonstrates cost-effectiveness of Ottawa Model for Smoking Cessation

Study demonstrates cost-effectiveness of Ottawa Model for Smoking Cessation

In a recent study published in Tobacco Control, researchers at the University of Ottawa Heart Institute have demonstrated the cost-effectiveness of the Ottawa Model for Smoking Cessation (OMSC), an intervention that includes in-hospital counseling, pharmacotherapy and post-hospital follow-up, compared to usual care among smokers hospitalized with acute myocardial infarction, unstable angina, heart failure, and chronic obstructive pulmonary disease. [More]
iGetBetter selects Validic platform to access data from broad range of biometric devices

iGetBetter selects Validic platform to access data from broad range of biometric devices

iGetBetter, Inc., a supplier of post-acute care transition solutions, and Validic, the healthcare industry's premier technology platform for accessing digital health data, announced today that iGetBetter has selected the Validic platform to access data from a broad range of available biometric devices as part of its care transition solution focused on reducing readmissions. [More]
Volatile organic compounds in exhaled breath show presence and stage of lung cancer

Volatile organic compounds in exhaled breath show presence and stage of lung cancer

Results of a University of Colorado Cancer Center study presented at the 50th Annual Meeting of the American Society for Clinical Oncology (ASCO) show that a test of organic compounds in exhaled breath can not only distinguish patients with lung cancer from patients with chronic obstructive pulmonary disease (COPD), but can also define the stage of any cancer present. [More]
Researchers develop virtual platform that measures level of addiction of smokers

Researchers develop virtual platform that measures level of addiction of smokers

In Mexico, 21.7 percent of the population smokes, which is associated with 95 percent of 
lung cancer cases and the development of 29 more different conditions. [More]